Online Program Home
My Program

Abstract Details

Activity Number: 352 - Clinical Trials: Recent Advances in Design and Inference
Type: Contributed
Date/Time: Tuesday, July 31, 2018 : 10:30 AM to 12:30 PM
Sponsor: Biometrics Section
Abstract #329099 Presentation
Title: Estimation of Treatment Effect in Enriched Clinical Trials: Application to Multiple Sclerosis
Author(s): Rachel MacKay Altman*
Companies: Simon Fraser University
Keywords: Negative binomial; Enrichment; Clinical trials; Bias adjustment; Multiple sclerosis; Efficiency
Abstract:

In enriched clinical trials, the study population is selected in hopes of increasing the power to detect treatment effect. For example, in enriched multiple sclerosis (MS) clinical trials, patients are often chosen based on their disease activity (as measured by the presence of brain lesions). While lesion counts in the general population of MS patients over the course of a trial are well-described by the negative binomial (NB) distribution, counts in this specially chosen subpopulation are not NB distributed. Previous work suggests that bias in the treatment effect estimator results when the NB model is naively fit to such data, and that standard inferential procedures may be invalid. In this paper, we show how to quantify this bias analytically. More importantly, we propose an alternative, simple estimator that is approximately unbiased and can form the basis of approximately valid inferential procedures. Our estimator and its standard error have the advantage of being distribution-free; hence, our results apply not only to counts arising from enriched MS trials, but extend to responses with any distribution, regardless of whether an enrichment design is used.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program